Loading provider…
Loading provider…
Gastroenterology Physician in New York, NY
NPI: 1023093721Primary Practice Location
New York Gastroenterology and Hepatology PC
5030 Broadway, New York, NY
Primary Employer
Allied Digestive Health Medical Group of New York
allieddigestivehealth.com
HQ Phone
Get MD Jonathan's Phone Numberphone_androidMobile
Get MD Jonathan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
1996 - 2026

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Gastroenterology
NYU Grossman School of Medicine
med.nyu.edu
Fellowship • Gastroenterology
1997 - 2000
New York Presbyterian Hospital (Columbia Campus)
Residency • Internal Medicine
1994 - 1997
New York Medical College
nymc.edu
Medical School
Until 1994
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 92 | 143 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 90 | 136 |
| 3 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 40 | 40 |
| 4 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 30 | 30 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 30 | 30 |
Synchronous gastric adenocarcinomas in a patient with Meckel's diverticulum.
Authors: Jonathan M. Rieber, Elizabeth H. Weinshel, Tan Nguyen, Gurdip S. Sidhu, Edmund J. Bini
Publication Date: 2001-07
Prospective, randomized, single-blind comparison of two preparations for screening flexible sigmoidoscopy ☆
Authors: Edmund J. Bini, Jeffrey S. Unger, Jonathan M. Rieber, Jonathan Rosenberg, Karin Trujillo, Elizabeth H. Weinshel
Publication Date: 2000-08
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo SC, DRUG: Mirikizumab SC, DRUG: Mirikizumab IV
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab